Literature DB >> 15002732

Astrocytic response in hippocampus and cerebral cortex in an experimental epilepsy model.

Elena Girardi1, Alberto Javier Ramos, Gabriela Vanore, Alicia Brusco.   

Abstract

Astrocytes are very sensitive to alterations in the brain environment and respond showing a phenomenon known as astroglial reaction. S100beta is an astroglial derived neurotrophic factor, seems to be involved in neuroplasticity. The aim of this work was to study the astrocytic response in rat hippocampus and cerebral cortex after repetitive seizures induced by 3-mercaptopropionic acid (MP) administration. Immunocytochemical studies were performed to analyze GFAP and S100beta expression. Both studied areas showed hypertrophied astrocytes with enlarged processes and increased soma size. Astrocyte hyperplasia was observed only in the cerebral cortex. A significant decrease in the astrocytic S100beta immunostaining occurs after MP treatment. These results indicate that MP administration induces an astroglial reaction with reduced intracellular S100beta level. The observed reduction in astroglial S100beta could be related to the release of this factor to the extracellular space, where it may produce neurotrophic or deleterious effects accordingly to the concentration achieved. The mechanism of this remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002732     DOI: 10.1023/b:nere.0000013739.15160.a8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

1.  Characterization of reactive astrocytes in the chronic phase of the pilocarpine model of epilepsy.

Authors:  Cibele L Garzillo; Luiz E A M Mello
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

2.  Functional and molecular properties of human astrocytes in acute hippocampal slices obtained from patients with temporal lobe epilepsy.

Authors:  W Schröder; S Hinterkeuser; G Seifert; J Schramm; R Jabs; G P Wilkin; C Steinhäuser
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

3.  Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions.

Authors:  L A Zimmer; M Ennis; M T Shipley
Journal:  J Comp Neurol       Date:  1997-02-24       Impact factor: 3.215

4.  Convulsant activity of homocysteine and other short-chain mercaptoacids: protection therefrom.

Authors:  H Sprince; C M Parker; J A Josephs; J Magazino
Journal:  Ann N Y Acad Sci       Date:  1969-09-30       Impact factor: 5.691

5.  S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes.

Authors:  J Hu; F Castets; J L Guevara; L J Van Eldik
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

6.  The effect of the convulsant 3-mercaptopropionic acid on enzymes of the gamma-aminobutyrate system in the rat cerebral cortex.

Authors:  M Alberici de Canal; B Robiolo; M Mistrorigo de Pacheco
Journal:  J Neurochem       Date:  1973-09       Impact factor: 5.372

7.  Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration.

Authors:  L Giraldez; F Zanetti; E Girardi
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

8.  2,4-dichlorophenoxyacetic acid through lactation induces astrogliosis in rat brain.

Authors:  A Brusco; J P Saavedra; G García; P Tagliaferro; A M Evangelista de Duffard; R Duffard
Journal:  Mol Chem Neuropathol       Date:  1997-04

9.  Citrate synthase activity increases in homogenates of the cerebral cortex from rats treated with the convulsant 3-mercaptopropionic acid.

Authors:  E Girardi; G R Lores Arnaiz
Journal:  Neurochem Int       Date:  1985       Impact factor: 3.921

10.  Immunocytochemical evidence for a distinct GFAP-negative subpopulation of astrocytes in the adult rat hippocampus.

Authors:  W Walz; M K Lang
Journal:  Neurosci Lett       Date:  1998-12-04       Impact factor: 3.046

View more
  9 in total

1.  3-mercaptopropionic acid-induced seizures decrease NR2B expression in Purkinje cells: cyclopentyladenosine effect.

Authors:  E Girardi; J Auzmendi; N Charó; M B Gori; M Castro
Journal:  Cell Mol Neurobiol       Date:  2010-07-13       Impact factor: 5.046

2.  Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.

Authors:  Wagner C Martins; Vanessa Valgas dos Santos; Alessandra Antunes dos Santos; Samuel Vandresen-Filho; Tharine A Dal-Cim; Karen A de Oliveira; Claudia B N Mendes-de-Aguiar; Marcelo Farina; Rui Daniel Prediger; Giordano Gubert Viola; Carla I Tasca
Journal:  Neurotox Res       Date:  2015-04-01       Impact factor: 3.911

3.  3-Mercaptopropionic acid-induced repetitive seizures increase GluN2A expression in rat hippocampus: a potential neuroprotective role of cyclopentyladenosine.

Authors:  María Belén Gori; Elena Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-06-08       Impact factor: 5.046

4.  Dietary restriction enhances kainate-induced increase in NCAM while blocking the glial activation in adult rat brain.

Authors:  Sandeep Sharma; Gurcharan Kaur
Journal:  Neurochem Res       Date:  2007-11-10       Impact factor: 3.996

5.  Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.

Authors:  Christina R Marmarou; Xiuyin Liang; Naqeeb H Abidi; Shanaz Parveen; Keisuke Taya; Scott C Henderson; Harold F Young; Aristotelis S Filippidis; Clive M Baumgarten
Journal:  Brain Res       Date:  2014-06-13       Impact factor: 3.252

6.  The NMDAR subunit NR2B expression is modified in hippocampus after repetitive seizures.

Authors:  J Auzmendi; N González; Elena Girardi
Journal:  Neurochem Res       Date:  2008-08-27       Impact factor: 3.996

7.  Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.

Authors:  Alberto Lazarowski; Alberto Javier Ramos; Hernán García-Rivello; Alicia Brusco; Elena Girardi
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

Review 8.  Preclinical evidence of ghrelin as a therapeutic target in epilepsy.

Authors:  Tongtong Ge; Wei Yang; Jie Fan; Bingjin Li
Journal:  Oncotarget       Date:  2017-06-02

9.  Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study.

Authors:  Maryam Bagheri; Arjang Rezakhani; Sofie Nyström; Maria V Turkina; Mehrdad Roghani; Per Hammarström; Simin Mohseni
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.